UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.8920-0.0080 (-0.89%)
As of 11:15AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2021
30/04/2020
30/04/2019
Total revenue
0
0
0
0
Operating expenses
Research development
3,833
1,311
1,069
3,700
Selling general and administrative
5,834
3,641
3,355
1,309
Total operating expenses
9,667
4,952
4,424
5,009
Operating income or loss
-9,667
-4,952
-4,424
-5,009
Interest expense
82.779
158.803
-
-
Total other income/expenses net
-
62.418
-
-
Income before tax
-9,749
-5,047
-4,410
-4,862
Income from continuing operations
-9,749
-5,047
-4,410
-4,862
Net income
-9,749
-5,047
-4,410
-4,862
Net income available to common shareholders
-9,749
-5,047
-4,410
-4,862
Basic EPS
-
-0.06
-0.05
-0.05
Diluted EPS
-
-0.06
-0.05
-0.05
Basic average shares
-
84,930
88,754
88,754
Diluted average shares
-
84,930
88,754
88,754
EBITDA
-
-4,888
-4,424
-5,009